Texas Cardiac Arrhythmia Institute leader participates in clinical trial for catheter that may reduce complication risk during cardiac ablation

AUSTIN, Texas, May 26, 2021 /PRNewswire/ — The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center participated in a clinical study to evaluate the safety and effectiveness of a new lattice sphere catheter designed to optimize procedural efficiency and efficacy across a broad range of cardiac arrhythmias. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, recently participated in the first-in-human trials of this catheter in Europe.

“This new transformative technology enables a faster and more precise process for how we deliver energy during complex ablation procedures,” Dr. Natale said. “The treatment provides a safer option for patients, as it may prevent collateral damage to surrounding tissue to ensure the best possible outcomes.”

The new expandable, cardiac-specific catheter is used to deliver focal pulsed field ablation (PFA) and/or radiofrequency ablation (RFA). PFA delivers pulsed electric field, a non-thermal energy modality, to ablate cardiac tissue through a process known as irreversible electroporation (IRE), while RFA ablates tissue thermally using radiofrequency.

The ablation catheter has an expandable lattice sphere at its tip, which allows physicians to create high-resolution maps and deliver a controlled and tailored ablation procedure using PFA or RFA. Additionally, the mapping system is integrated with the device and enables the rapid creation of detailed electroanatomical maps, providing increased accuracy and improving patient outcomes.

This technology is expected to be available to patients at TCAI next year.

Media Contact:
Stacy Slayden
Elizabeth Christian Public Relations
254.592.2767 cell

Previous Article

معرض هايف للمفروشات ينطلق من دبي بمشاركة 55 عارضاً

Next Article

‫شركة إكس سي إم جي توفر طلبية كبيرة من 100 جرافة طراز LW500FN لدول مبادرة الحزام والطريق جنوب شرق آسيا

Related Posts

GEODIS strengthens its capabilities for air freight temperature-controlled pharmaceutical shipments across Asia Pacific and Middle East

CEIV certification is an assurance of the quality of transportation for healthcare companies in the region. SINGAPORE – Media OutReach– 13 April 2023 – Leading global logistics operator GEODIS has announced that it has strengthened its air freight temperature-controlled pharma shipments capabilities in Asia Pacific and Middle East (APAC&ME) with the Center of Excellence for […]

ROSEN, A LEADING LAW FIRM, Encourages Terra Tokens Investors to Secure Counsel Before Important Deadline in Securities Class Action – UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI, MINE, aUST, vUST, MIR, mBTC, mETH, mVIXY, mTSLA, UST-mVIXY-LP, bLUNA-LUNA-LP, XDEFI-UST-LP, bLUNA, bETH

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Terra Tokens, including UST, LUNA, KRT, ANC, WHALE, ASTRO, APOLLO, XDEFI, MINE, aUST, vUST, MIR, Mirrored Assets (e.g. mBTC, mETH, mVIXY, mTSLA, etc.), Liquidity Pool tokens (e.g. UST-mVIXY-LP, bLUNA-LUNA-LP, XDEFI-UST-LP, etc.) and/or Bonded Assets […]

“GigaFarm” capable of replacing 1% of UAE food imports set for construction in Dubai Food Tech Valley

ReFarm and IGS announced the partnership from their demonstration facility in Dubai Back row (L-R): HE Eng. Mohammed Mousa Alameeri (Assistant Undersecretary for the Food Diversity Sector, Ministry of Climate Change and Environment, UAE), HE Mohammed Saeed Al Nuaimi (Acting Undersecretary of the Ministry of Climate Change and Environment, UAE), The Rt Hon Lord Benyon […]

The single-component Sputnik Light vaccine authorized in Egypt

MOSCOW, Sept. 24, 2021 /PRNewswire/ — The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Egyptian Drug Authority (EDA). Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. Immunization […]